Ginkgo Bioworks Holdings, Inc. (DNA) ended the recent trading session at $15.12, demonstrating a -4.49% change from the preceding day's closing price. The stock trailed the S&P 500, which registered ...

Ginkgo Bioworks Holdings has seen its consensus analyst price target rise from $11.33 per share to $12.00 per share. This reflects a modest but noteworthy vote of confidence from the market. The ...

Ginkgo Bioworks Holdings, Inc. (DNA) reached $15.24 at the closing of the latest trading day, reflecting a -5.28% change compared to its last close.

Recursion Pharmaceuticals' stock rises on heavy trading volume, with investors eyeing its AI-designed cancer drug REC-3565 ...

Wells Fargo analyst Aaron Rakers maintained Dell with an Overweight rating and raised the price target from $160 to $180, ...

NEW YORK (AP) — If the U.S. government's latest shutdown can't stop the stock market, what can? Stock prices keep rising, even as the shutdown delays important economic reports that usually steer ...

It's here, and it's all shiny and new. Pokémon TCG has moved on from its Scarlet & Violet series of expansions and is now in its official Mega Evolution era. The first of which is aptly titled "Mega ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Lucid Group Inc. (NASDAQ: LCID) is a luxury EV maker with ...

Stocks closed at record highs Wednesday despite a U.S. government shutdown expected to idle hundreds of thousands of workers and hobble federal agencies charged with dispensing a range of critical ...